Jounce Therapeutics, Inc.
Antibodies to LILRB2

Last updated:

Abstract:

Provided herein are various embodiments relating to antibodies that bind LILRB2. Anti-LILRB2 antibodies can be used in methods to treat disease, for example, cancer.

Status:
Grant
Type:

Utility

Filling date:

20 Dec 2018

Issue date:

28 Jul 2020